Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy

被引：31

作者：

Gong, Dao-Jun ^{[1
]}

Miao, Chao-Feng ^{[1
]}

Bao, Qi ^{[1
]}

Jiang, Ming ^{[1
]}

Zhang, Li-Fang ^{[1
]}

Tong, Xiao-Tao ^{[1
]}

Chen, Li ^{[1
]}

机构：

[1] Zhejiang Univ, Dept Surg, Coll Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2008年 / 14卷 / 42期

关键词：

Gastric cancer; Total gastrectomy; Morbidity; Mortality; Risk factor;

D O I：

10.3748/wjg.14.6560

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AIM: To study the risk factors for morbidity and mortality following total gastrectomy. METHODS: We retrospectively reviewed the records of 125 consecutive patients who underwent total gastrectomy for gastric cancer at the Second Affiliated Hospital of Zhejiang University School of Medicine between January 2003 and March 2008. RESULTS: The overall morbidity rate was 20.8% (27 patients) and the mortality rate was 3.2% (4 patients). Morbidity rates were higher in patients aged over 60 [odds ratio (OR) 4.23 (95% confidence interval (CI) 1.09 to 12.05)], with preoperative comorbidity [with vs without, OR 1.25 (95% CI 1.13 to 8.12)], when the combined resection was performed [combined resection vs total gastrectomy only, OR 2.67 (95% CI 1.58 to 5.06)]. CONCLUSION: Age, preoperative comorbidity and combined resection were independently associated with the rate of morbidity after total gastrectomy for gastric cancer. (c) 2008 The WJG Press. All rights reserved.

引用

页码：6560 / 6563

页数：4

共 26 条

[11] Proposed mechanisms of transfusion-induced immunomodulation [J].

Kirkley, SA .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (05) :652-657

[12] Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study [J].

McCulloch, P ;

Ward, J ;

Tekkis, PP .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7425) :1192-1196

[13] The role of surgery in patients with advanced gastric cancer [J].

McCulloch, Peter .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (04) :767-787

[14]

Meyer HJ, 1999, SEMIN SURG ONCOL, V17, P117, DOI 10.1002/(SICI)1098-2388(199909)17:2<117::AID-SSU6>3.0.CO

[15]

2-7

[16]

OPELZ G, 1973, TRANSPLANT P, V5, P253

[17] Predictors of operative morbidity and mortality in gastric cancer surgery [J].

Park, DJ ;

Lee, HJ ;

Kim, HH ;

Yang, HK ;

Lee, KU ;

Choe, KJ .

BRITISH JOURNAL OF SURGERY, 2005, 92 (09) :1099-1102

[18] Current status and future perspectives in gastric cancer management [J].

Roukos, DH .

CANCER TREATMENT REVIEWS, 2000, 26 (04) :243-255

[19] Postoperative infections after oesophageal resections: The role of blood transfusions [J].

Rovera F. ;

Dionigi G. ;

Boni L. ;

Imperatori A. ;

Tabacchi A. ;

Carcano G. ;

Diurni M. ;

Dionigi R. .

World Journal of Surgical Oncology, 4 (1)

[20] Complications after surgery for gastric cancer in patients aged 80 years and over [J].

Roviello, F ;

Marrelli, D ;

De Stefano, A ;

Messano, A ;

Pinto, E ;

Carli, A .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (02) :116-122

← 1 2 3 →